Dune Medical Devices, a Framingham company specializing in the early detection of breast cancer, is relocating to Boston’s Seaport District, said a broker involved in the transaction.
The broker is Cassidy Turley, a commercial real estate services firm.
Cassidy Turley said that Dune Medical Devices has signed a lease for space at 25 Thomson Place.
Dune Medical Devices is the manufacturer of the MarginProbe System, an intra-operative assessment device for early-stage breast cancer surgery.
“The growth opportunities and future potential of Boston’s Seaport District mirror the bright future of Dune Medical Devices and our proprietary tissue assessment technology,” Dune Medical Devices chief executive Dan Levangie said in a statement. “As our company continues to grow and innovate, we look forward to working in an urban office environment where we can foster innovation and easily accommodate the positive changes our organization will experience in the years to come.”